RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 111 filers reported holding RAPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193 | -10.6% | 11,611 | +0.7% | 0.00% | – |
| Q2 2023 | $216 | -28.2% | 11,528 | -29.8% | 0.00% | – |
| Q1 2023 | $301 | -25.1% | 16,428 | -19.2% | 0.00% | -100.0% |
| Q4 2022 | $402 | -99.9% | 20,328 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $489,000 | +32.2% | 20,328 | +0.3% | 0.00% | – |
| Q2 2022 | $370,000 | +11.4% | 20,260 | +34.2% | 0.00% | – |
| Q1 2022 | $332,000 | -38.7% | 15,092 | +2.3% | 0.00% | -100.0% |
| Q4 2021 | $542,000 | +37.6% | 14,755 | +16.4% | 0.00% | – |
| Q3 2021 | $394,000 | -19.9% | 12,677 | -18.2% | 0.00% | -100.0% |
| Q2 2021 | $492,000 | +119.6% | 15,490 | +53.4% | 0.00% | – |
| Q1 2021 | $224,000 | +12.6% | 10,100 | 0.0% | 0.00% | – |
| Q4 2020 | $199,000 | -38.8% | 10,100 | 0.0% | 0.00% | – |
| Q3 2020 | $325,000 | +10.9% | 10,100 | 0.0% | 0.00% | – |
| Q2 2020 | $293,000 | +946.4% | 10,100 | +676.9% | 0.00% | – |
| Q1 2020 | $28,000 | -72.5% | 1,300 | -64.9% | 0.00% | – |
| Q4 2019 | $102,000 | – | 3,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |